Journal articleHepatol Commun · August 1, 2026
BACKGROUND: Immune-mediated liver injury from checkpoint inhibitors develops in up to 10% of treated patients. The aim of this study was to describe the relationship between standard liver histopathological findings and clinical presentation and outcomes i ...
Full textLink to itemCite
Journal articleClin Pharmacol Ther · July 25, 2026
Elevated aminotransferases with concomitant jaundice in drug-induced liver injury (DILI) are associated with adverse outcomes, but the prognostic significance of very high aminotransferases without jaundice is unclear. We examined selected outcomes of pati ...
Full textLink to itemCite
Journal articleJAMA Netw Open · May 2, 2022
IMPORTANCE: Studies comparing contemporary bariatric surgical types could facilitate procedure selection for patients interested in reducing their frequency of health care visits and reliance on prescription drugs. OBJECTIVE: To compare the association of ...
Full textLink to itemCite